Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec;42(6):877-884.
doi: 10.19852/j.cnki.jtcm.20220425.002.

Celastrol promotes apoptotic cell death in children neuroblastoma cells through caspases dependent pathway

Yang Ye  1 , Zhang Aihui  1 , L I Anmao  1
Affiliations

Celastrol promotes apoptotic cell death in children neuroblastoma cells through caspases dependent pathway

Yang Ye et al. J Tradit Chin Med. 2022 Dec.

Abstract

Objective: To investigate the in-depth pharma-cological mechanisms of celastrol in children neuro-blastoma treatment.

Methods: In the current study, we examined the effects of celastrol on children neuroblastoma cells viability and proliferation by cell counting kit-8 assay and colony formation assay. Annexin V-FTIC and PI staining were applied to determine cell apoptosis after celastrol treatment. ROS generation levels were examined by 2', 7'-dichloroflfluorescin diacetate.

Results: We found that celastrol could suppress the proliferation of children neuroblastoma cells with few effects on normal cell lines . Further mechanisms studies have shown that celastrol inhibited cell cycle progression and induced cell apoptosis in QDDQ-NM and SH-SY5Y cells. In addition, ROS production might involve in celastrol-mediated apoptotic cell death in children neuroblastoma cells by activating caspase death pathway.

Conclusions: Our findings demonstrated that celastrol could promote ROS generation-induced apoptosis in neuroblastoma cell by activating caspase death pathway. These findings suggested that celastrol might be a potential novel anti-neuroblastoma agent with minor cytotoxicity.

Keywords: apoptosis; celastrol; child; neuroblastoma; poly (ADP-ribose) polymerases.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Celastrol inhibits cell viability and proliferation of neuroblastoma cells
A: molecular structure of celastrol; B: QDDQ-NM, SK-N-SH and SH-SY5Y neuroblastoma cell lines and three normal cell lines were incubated with different concentrations (0-20 µM) of celastrol, CCK-8 assay was applied to determine cells viability. aP < 0.05; bP < 0.01 versus 0 μM celastrol treatment group; C: C1-C4: QDDQ-NM cell lines were incubated with different concentrations (0-20 µM) of celastrol; C5-C8: SK-N-SH cells were incubated with different concentrations (0-20 µM) of celastrol; C9-C12: SH-SY5Y cells were incubated with different concentrations (0-20 µM) of celastrol; C13-C16: BJ cells were incubated with different concentrations (0-20 µM) of celastrol; C17-C20: CCD-1079SK cells were incubated with different concentrations (0-20 µM) of celastrol; C21-C24: HUVEC cells were incubated with different concentrations (0-20 µM) of celastrol, cell morphology changes were detected by optical microscope. Scale bar = 100 μm; D: colony formation results after celastrol treatment (0-20 µM) in QDDQ-NM (D1-D4) and SH-SY5Y cells (D5-D8). aP < 0.05; bP < 0.01; cP < 0.001 versus control group; E: number of colonies after different concentrations of celastrol treatment 0, 5, 10, 20 µM. CCK-8: cell counting kit-8.
Figure 2
Figure 2. Celastrol inhibits cell cycle progression and induces cell apoptosis in QDDQ-NM and SH-SY5Y cells
A: flow cytometry assay we applied to detect the cells cycle distribution in QDDQ-NM cells after treatment with different concentrations of celastrol (A1) 0 µM, (A2) 5 µM, (A3) 10 µM,(A4) 20 µM for 1 d; B: quantitative analysis of cell cycle distribution was shown after celastrol treatment; C: the protein expressions of P21 were detected by immunoblotting in QDDQ-NM and SH-SY5Y cells after different concentrations of celastrol treatment; D: QDDQ-NM cells with Hoechst (bright blue) and PI (red) fluorescence signals were identified as apoptotic cells, (D1, D4, D7, D10) Hoechst stanning for 0, 5, 10, 20 µM celastrol treatment; (D2, D5, D8, D11) PI stanning for 0, 5, 10, 20 µM celastrol treatment; (D3, D6, D9, D12) Merged stanning for 0, 5, 10, 20 µM celastrol treatment; scale bar = 50 μm. E: the percentage of cell death rate after celastrol treatment. F, G: flow cytometry assay was applied to determine the apoptosis of QDDQ-NM (a) and SH-SY5Y (b) cells after celastrol treatment. aP < 0.05, bP < 0.01, cP < 0.001 compared to control.
Figure 3
Figure 3. Celastrol facilitates apoptosis in QDDQ-NM and SH-SY5Y cells by activating caspases pathway
A: mRNA expressions of Caspase-9, Bcl-2, PUMA, Bax, Noxa, and Caspase-3 were examined via RT-PCR assay; B: quantitative analysis of RT-PCR results; C-F: Western blotting and quantification results of the expressions of anti-apoptosis and pro-apoptosis proteins in QDDQ-NM and SH-SY5Y cells after celastrol treatment. G: cell viability of QDDQ-NM and SH-SY5Y were examined by CCK-8 assay after combined treatment with Z-VAD-FKM (caspase inhibitor) and celastrol. PUMA: p53 up-regulated modulator of apoptosis; RT-PCR: reverse transcription polymerase chain reaction; CCK-8: cell counting kit-8. aP < 0.05, aP < 0.01 versus control and cP < 0.01 versus celastrol treatment group.
Figure 4
Figure 4. ROS production was involved in celastrol-mediated apoptosis
A, B: ROS production was examined under fluorescence microscope by DCFH-DA staining and the relative DCF fluorescence intensities was quantified by Imagelab; A1-A3: QDDQ-NM cells for control group, celastrol group, celastrol with NAC group; A4-A6: SH-SY5Y cells for control group, celastrol group, celastrol with NAC group; C: flow cytometry assay was also applied to assess the effect of NAC on celastrol-mediated ROS production; D: the percentage of cell viability after celastrol treatment. aP < 0.01 compared to control, bP < 0.01 compared to celastrol-pretreated group. E, F: chromatin-condensed nuclei (red arrow) indicated cell apoptosis after staining with Hoechst 33442 dye. E1-E4: QDDQ-NM cells for control group, NAC group, celastrol group, celastrol with NAC group; E5-E8: SH-SY5Y cells for control group, NAC group, celastrol group, celastrol with NAC group. The images were detected by the fluorescence microscope. Scale bar = 50 μm. The proportion of Hoechst 33442+ cells were quantified by Imagelab. G, H: Annexin V and PI were used to stain the apoptosis cells by flow cytometry. The percentage of apoptosis cells of QDDQ-NM and SH-SY5Y were quantified by Imagelab. aP < 0.01, compared to untreated cells; bP < 0.01, cP < 0.05, compared to celastrol treatment cells. ROS: reactive oxygen species; DCFH-DA: 2, 7-Dichlorodihydrofluorescein diacetate; DCF: 2′, 7′-Dichlorodihydrofluorescein; NAC: N-Acetyl-L-cysteine.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Polito L, Bortolotti M, Pedrazzi M, Mercatelli D, Battelli MG, Bolognesi A. . Apoptosis and necroptosis induced by stenodactylin in neuroblastoma cells can be completely prevented through caspase inhibition plus catalase or necrostatin-1. Phytomedicine 2016; 23: 32-41. - PubMed
    1. Naveen CR, Gaikwad S, Agrawal-Rajput R.. Berberine induces neuronal differentiation through inhibition of cancer stemness and epithelial-mesenchymal transition in neuroblastoma cells. Phytomedicine 2016; 23: 736-44. - PubMed
    1. Fukuyama K, Kakio S, Nakazawa Y, et al. . Roasted coffee reduces beta-amyloid production by increasing proteasomal beta-secretase degradation in human neuroblastoma SH-SY5Y cells. Mol Nutr Food Res 2018; 62: e1800238. - PubMed
    1. Alberto F, Mario L, Sara P, Settimio G, Antonella L.. Electro-magnetic information delivery as a new tool in translational medicine. Int J Clin Exp Med 2014; 7: 2550-6. - PMC - PubMed
    1. Unno K, Pervin M, Nakagawa A, et al. . Blood-brain barrier permeability of green tea catechin metabolites and their neuritogenic activity in human neuroblastoma SH-SY5Y cells. Mol Nutr Food Res 2017; 61. - PubMed

Publication types